BlackRock Group’s AMAG Pharmaceuticals AMAG Stock Holding History

BlackRock Group’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.26M	Buy	65,082 +24,125	+59%	+$721K	﹤0.01%	1689
2016 Q3	$1M	Sell	40,957 -6,166	-13%	-$154K	﹤0.01%	2035
2016 Q2	$1.13M	Sell	47,123 -1,040	-2%	-$23.8K	﹤0.01%	1910
2016 Q1	$1.13M	Buy	48,163 +40,173	+503%	+$953K	﹤0.01%	1884
2015 Q4	$242K	Buy	7,990 +2,782	+53%	+$89.9K	﹤0.01%	2464
2015 Q3	$207K	Hold	5,208	–	–	﹤0.01%	2524
2015 Q2	$360K	Hold	5,208	–	–	﹤0.01%	2378
2015 Q1	$285K	Hold	5,208	–	–	﹤0.01%	2378
2014 Q4	$222K	Sell	5,208 -718	-12%	-$25.9K	﹤0.01%	2502
2014 Q3	$189K	Sell	5,926 -204	-3%	-$4.35K	﹤0.01%	2469
2014 Q2	$127K	Sell	6,130 -4,219	-41%	-$78K	﹤0.01%	2552
2014 Q1	$201K	Buy	10,349 +8,183	+378%	+$174K	﹤0.01%	2468
2013 Q4	$52K	Sell	2,166 -4,840	-69%	-$114K	﹤0.01%	2545
2013 Q3	$150K	Buy	7,006 +4,840	+223%	+$114K	﹤0.01%	2543
2013 Q2	$48K	Buy	+2,166	New	+$47.7K	﹤0.01%	2444

Other funds holding AMAG

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Group's AMAG Position: Q4 2016 in Review

BlackRock Group increased its AMAG Pharmaceuticals (AMAG) stake by 59% in Q4 2016, buying an estimated $721K and bringing the position to 65,082 shares worth $2.26M. The position accounts for ﹤0.01% of the portfolio, ranked #1689.

BlackRock Group first reported a position in AMAG in Q2 2013 and has held it in 15 quarters since. 206 funds tracked by Wall St. Rank hold AMAG as of Q4 2016.

BlackRock Group held 65,082 shares of AMAG Pharmaceuticals worth $2.26M as of Q4 2016.
BlackRock Group bought 24,125 AMAG Pharmaceuticals shares in Q4 2016, an estimated $721K.
AMAG Pharmaceuticals made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1689 holding.
BlackRock Group first reported a position in AMAG Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
206 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.